NEP Earnings

NEP reported its FY2024Q4 earnings on 2025-01-28, showcasing a revenue of 294.00M against an estimate of 350.95M, resulting in a -16.23% surprise. The EPS was 0, surpassing the expected 0.52 by 0% . The stock experienced a -25.13% price change on the earnings day and a -33.29% change over the next five days, reflecting market reactions to the results.

Following NEP's FY2024Q4 earnings announcement on 2025-01-28, the stock price moved by -25.13% on the day of the release. Over the subsequent five days, it saw a -33.29% change. Historically, NEP's stock price tends to shift by an average of +5.27% in the 10 days leading up to earnings and -0.97% in the 10 days following, providing insight into potential market.

For 2025/Q1, analysts estimate NEP’s annual revenue to reach 303.58M, while the EPS is projected at -0.15. These estimates reflect recent revisions, with revenue estimates revised Revenue No Change by % and EPS estimates No Change by % over the past three months, indicating analyst expectation in the company’s performance.

The correlation between NEP's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock’s fundamentals. Over the past three months, revenue estimates for were No Change by %, while EPS estimates moved No Change by % . This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, NEP's stock price typically moves by +5.27% in the 10 days before its earnings and -0.97% in the 10 days after. For the upcoming 2025/Q1 earnings, analysts expect an EPS of -0.15 and revenue of 303.58M.

The earnings call reveals several concerns: heavy reliance on equity markets, significant debt financing, and suspension of unitholder distributions. The Q&A section highlights management's evasiveness on key financial metrics, adding uncertainty. Despite stable EBITDA and free cash flow projections, the lack of clear growth guidance and operational risks from strategic shifts contribute to a negative outlook. The indefinite suspension of distributions and potential regulatory risks further exacerbate investor concerns, leading to a likely negative stock price movement.